Philips Slumps After Another Blow to US Sleep Devices Recall (2)

Royal Philips NV suffered another setback as the US drug regulator requested additional tests on its sleep apnea devices, warning that the company’s analysis of the recalled products is inadequate.

Further testing is required to “fully evaluate the risks” after initial results showed exposure to the devices is unlikely to cause considerable health damage to patients, the US Food and Drug Administration said in a statement on Thursday.The Dutch company’s shares fell as much as 10% in Amsterdam, the most in a year.

The maker of medical gear initiated a recall of the so-called BiPAP and CPAP machines in ...